These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Effect of cicletanine on a sudden death model in dogs]. Guillon JM; Thievant P; Braquet P Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():151-4. PubMed ID: 2514657 [TBL] [Abstract][Full Text] [Related]
5. [Therapeutic effect of p-tyrosol on myocardial electric instability induced by coronary occlusion]. Chernyshov GA; Plotnikov MB; Smol'iakova VI; Krasnov EA Eksp Klin Farmakol; 2007; 70(4):23-5. PubMed ID: 18078037 [TBL] [Abstract][Full Text] [Related]
7. A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Singh BN; Vaughan Williams EM Br J Pharmacol; 1970 Aug; 39(4):675-87. PubMed ID: 5485144 [TBL] [Abstract][Full Text] [Related]
8. [Effect of lithium hydroxybutyrate and lithium chloride on heart rhythm disorders of various origins]. Galenko-Iaroshevskiĭ PA; Shadurskiĭ KS; Tikhonov AV Farmakol Toksikol; 1984; 47(4):54-9. PubMed ID: 6090202 [TBL] [Abstract][Full Text] [Related]
10. [Comparative study of different classes of anti-arrhythmia agents on the vulnerability of ischemic ventricular fibrillation]. Aupetit JF; Timour Q; Chevrel G; Omar S; Loufoua-Moundanga J; Faucon G Therapie; 1993; 48(4):403-7. PubMed ID: 8128424 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacologic treatment for ventricular arrhythmias]. Halawa B Pol Merkur Lekarski; 1997 Aug; 3(14):45-9. PubMed ID: 9480172 [TBL] [Abstract][Full Text] [Related]
12. Observations on the genesis of ventricular fibrillation in the course of a temporary occlusion of the coronary artery. II. Wojtowicz M; Dybicki J; Zawistowski S; Wrzolek S; Bartoszewicz T Pol Med J; 1967; 6(2):479-81. PubMed ID: 6030655 [No Abstract] [Full Text] [Related]
13. Effects of diltiazem upon experimental ventricular dysrhythmias. Patterson E; Eller BT; Lucchesi BR J Pharmacol Exp Ther; 1983 Apr; 225(1):224-33. PubMed ID: 6834274 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacological profile of a new anti-arrhythmia agent: bunaftide]. Beani L Boll Soc Ital Cardiol; 1972; 17(12):1279-81. PubMed ID: 4681455 [No Abstract] [Full Text] [Related]
15. [Prognosis and management of patients with tachycardial heart arrhythmia ]. Steinbach K Wien Med Wochenschr; 1984 Oct; 134(19-20):425-6. PubMed ID: 6516418 [TBL] [Abstract][Full Text] [Related]
16. Long term management of the survivor of ventricular fibrillation or sustained ventricular tachycardia. Connolly SJ; Krahn A; Klein G Can J Cardiol; 2000 Jun; 16 Suppl C():20C-2C. PubMed ID: 10887273 [No Abstract] [Full Text] [Related]
18. [Effects of dauricine combined with other anti-arrhythmia agents on electrically induced ventricular fibrillation in rabbits]. Du ZH; Liu HG; Zeng FD; Hu CJ Zhongguo Yao Li Xue Bao; 1988 Jan; 9(1):33-6. PubMed ID: 3188931 [No Abstract] [Full Text] [Related]
19. [Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion]. Gülker H; Thale J; Brisse B; Bender F Z Kardiol; 1984 Aug; 73(8):515-24. PubMed ID: 6495811 [TBL] [Abstract][Full Text] [Related]